ALVO Alvotech
- 11.910
- -0.180-1.49%
Alvotech News
Alvotech Secures $965M for Growth and Refinancing
Express News | Alvotech Announces Closing of Private Debt Financing
Alvotech's AVT03 Shows Promising Study Results
Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints
Alvotech (ALVO) said Tuesday a confirmatory study for AVT03, a proposed biosimilar to Amgen's (AMGN) denosumab sold as Prolia and Xgeva, met its primary endpoints. The study aims to show clinical simi
Express News | Alvotech SA: Expects to File Marketing Applications for Avt03 Later This Year for Major Global Markets
Express News | Alvotech SA - Avt03 Study Meets Primary Endpoints
Express News | Alvotech Announces Positive Topline Results From Confirmatory Patient Study for Avt03, a Proposed Biosimilar for Prolia® and Xgeva®
Alvotech Expands Share Count With Bond Conversion
Express News | Alvotech- Issued Shares to Holders of Subordinated Convertible Bonds, Originally Issued on Nov 16, 2022, & Dec 20, 2022, With Maturity on Dec 20, 2025
Express News | Alvotech SA - Issued 22.1 Mln New Ordinary Shares in Exchange for Convertible Bonds, at Fixed Price of US$10.00 per Share
Alvotech Issues New Shares to Holders of Convertible Bonds
Alvotech (NASDAQ: ALVO) today issued new shares to holders of subordinated convertible bonds, originally issued by Alvotech on November 16, 2022, and December 20, 2022, with maturity on December 20, 2025 (the "Convertible Bonds").
6-K/A: Report of foreign private issuer (related to financial reporting)
When Will Alvotech (NASDAQ:ALVO) Become Profitable?
With the business potentially at an important milestone, we thought we'd take a closer look at Alvotech's (NASDAQ:ALVO) future prospects. Alvotech, through its subsidiaries, develops and manufactures
Alvotech Forecasts Record Revenues in 2024
Alvotech 1H Preliminary Revenue $233M-$238M, Up Sharply on Year >ALVO
Alvotech 1H Preliminary Revenue $233M-$238M, Up Sharply on Year >ALVO
Express News | Alvotech SA: Preliminary Q2 Adjusted Ebitda $98 - $103 Mln
Express News | Alvotech SA: Preliminary Q2 Revenue $196 - $201 Mln
Express News | Alvotech Announces Record Preliminary Results for Revenues and Ebitda for the Second Quarter of 2024
Express News | Alvotech Shares Are Trading Lower After the Company Announced That Holders of Majority Subordinated Convertible Bonds Elected to Convert the Principal and Accrued Interest Into Ordinary Shares at $10.00 per Share
Nordic Stocks Decrease Wednesday; Alvotech Falls Furthest
Nordic stocks fell Wednesday, with the OMX Nordic 40 Index declining 0.7%. Alvotech posted the largest decline among large stocks during the session, dropping 7.0%, followed by Leroy Seafood Group AS
Analysis
Price Target
No Data
